General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Sun Pharma Reports 26 Net Profit Growth in Q4 Driven by Strong Sales and Strategic Investments SpaceX Launches Upgraded Starship in 12th Test Flight as Public Listing Looms SpaceXs Starship Central to Valuation Early Investor Suggests Frontier Markets Await Wall Street Holds Near Record Highs as Oil Price Pulls Back US Treasury Yields Fall but ING Sees Upward Pressure on LongEnd Yields OPBK Q1 2026 Earnings EPS Surpasses Estimates by 146 EM Q2 2024 Earnings Stellar EPS Surprise of 42957 EGY Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline SES AI Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite WiderThanExpected Loss Loews Corporation Q1 2026 Earnings EPS of 163 Driven by Diversified Portfolio Werner Enterprises WERN Edges Higher as Trucking Sector Stabilizes Key Support and Resistance Levels in View Leapfrog Acquisition Warrants LFACW Hold Steady at 028 Amid Quiet Trading Oklo Inc OKLO Shows Modest Gains as Shares Test Key Resistance Levels ProFrac Holding ACDC Slips Lower as Pressure Persists Near Support Levels SAP Stock Edges Lower as Traders Eye Key Support at 16409 Chinese Drone Exports Decline Amid Domestic Crackdown and US Import Restrictions Epsilon Energy Ltd EPSN Q1 2026 Earnings Modest EPS Amid Low Volumes Stock Slightly Lower Ethan Allen Interiors ETD Holds Steady Near 1974 as Support and Resistance Levels Come into Focus AAPL Q1 2026 Earnings EPS Beat Exceeds Expectations on Strong Operational Execution BJ Q1 2026 Earnings EPS Beats Estimates but Shares Slide 825 on Mixed Signals CCSI Q1 2026 Earnings Strong EPS Beat Amidst Cautious Outlook KINS Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment WS Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline